Buscar resultados de ensayos clínicos
Lung Adenocarcinoma - 26 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Molecular Analysis of 150 Lung Adenocarcinoma Condición: Lung Adenocarcinoma Fecha: 2016-07-20 Intervenciones: Genetic: Sequencing Tumour samples are coming from routine histopathological procedure. They are used wi |
Active, not recruiting |
Nombre del estudio: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma Condición: Lung Adenocarcinoma Fecha: 2010-11-24 |
Active, not recruiting |
Nombre del estudio: Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy Condición: Lung Adenocarcinoma Fecha: 2011-11-28 Intervenciones: Other: CT, PET, copy number alteration Duel-energy CT, PET, copy number alteration |
Not yet recruiting |
Nombre del estudio: Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma Condición: Lung Adenocarcinoma Fecha: 2015-03-22 Intervenciones: Drug: Erlotinib, Pemetrexed followed classical chemotherapy for 4 cycles, use Erlotinib orally for the m |
Recruiting |
Nombre del estudio: Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma Condición: Lung Adenocarcinoma Fecha: 2014-12-16 Intervenciones:
|
Completed |
Nombre del estudio: Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib Condición: Lung Adenocarcinoma Fecha: 2008-07-15 Intervenciones: Drug: erlotinib with cetuximab The phase I portion will accrue as many as 3 cohorts of 3-6 patients; rec |
Recruiting |
Nombre del estudio: A Study Examining Maintenance Avastin Monotherapy in Patients With Advanced Lung Adenocarcinoma Condición: Lung Adenocarcinoma Fecha: 2014-03-19 |
Recruiting |
Nombre del estudio: Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma Condición: Lung Adenocarcinoma Fecha: 2015-11-25 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial Condición: Lung Adenocarcinoma Fecha: 2016-10-15 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR Condición: Lung Adenocarcinoma Fecha: 2016-02-03 Intervenciones:
|